妓院一钑片免看黄大片,亚洲av无码成人精品国产,亚洲AV综合色区无码专区桃色,免费A级毛片在线播放不收费

 辰欣藥業 Cisen Pharmaceutical   
辰欣藥業股份有限公司是一家綜合性化學藥品制劑生產企業。公司現為國家級高新技術企業、博士后科研工作站、山東省泰山學者藥學特聘專家設崗單位、山東省企業技術中心、山東省抗生素工程技術研究中心，獲得國家發改委產業化扶持基金、國家科技部科技型企業技術創新基金、中國專利山東明星企業等榮譽。2011年5月，“辰欣”商標被國家工商總局認定為“中國馳名商標”，同時入選2011中國醫藥研發產品線最佳工業企業及2011年中國醫藥工業最具投資價值企業。
　　公司秉承“推陳出新、誠實守信”的企業理念，堅持以科技為先導，以質量求生存，以創新求發展，走出了一條科技創新之路，先后投資建成了開發區第一工業園十五個生產車間和現代化的動物實驗樓及大型高架立體倉庫。2010年6月辰欣第二工業園隆重奠基，加速了辰欣藥業向工藝難度大、生命周期長、附加值高的新產品進軍的步伐。公司可生產大輸液（非 PVC 軟袋輸液、塑料瓶輸液、玻璃瓶輸液）、水針、凍干粉針、片劑、膏劑、滴眼劑、膠囊劑和小原料藥等八大劑型近 400個規格的產品。其中，輸液被評為山東省名牌產品，輸液產品產量位居國內單廠第一，水針產量居山東省第一位。
　　辰欣藥業以保障和提高病患者生命健康質量為己任，致力于自主研發、生產能夠填補國內空白的藥品。每年將銷售收入的6%用于科技研發投入，先后與中國藥科大學、沈陽藥科大學、山東大學、山東省醫科院、山東省醫藥工業研究所、中科院藥物研究所、軍事醫學科學院等科研院所建立了長期合作關系，成功走出了一條“產、學、研聯合創新”的路子，建立了從市場調研、開發設計到試制生產的一條龍開發體系，形成了研制一代、儲備一代、生產一代的良性循環。 新產品涵蓋了心腦血管類、抗菌、抗病毒類、抗癌類等多門類100多個品種。其中，由辰欣藥業自主研制的阿德福韋酯（原料及片劑）被評為國家一類新藥證書，獲得山東省科技進步一等獎，并獲得國家科技部、省、市科技創新基金扶持。該藥物的研制成功是我國在自主研發乙肝藥物治療領域取得的重大突破，對于推動我國醫藥產業的技術進步，加快我國醫藥高技術成果產業化，提高我國生物醫藥產業技術創新能力和國際競爭力具有重要意義，也將是辰欣品牌再次提升的發動機。
　　辰欣藥業非常重視產品的質量管理工作。我們堅持“質量第一，預防為主”的質量管理方針，秉承“藥因質盛，業以牌榮”的質量管理理念，建立了一整套縝密有效的質量保證體系，總經理對產品質量全面負責，公司質量保證部向各車間派駐質量員，對車間生產質量管理工作進行監督指導，使質量否決權落到實處。各車間在生產崗位設置工藝監控點，嚴把質量檢驗監督關。目前，公司所有劑型的產品全部通過了國家食品藥品監督管理局認證中心 GMP 認證和三體系認證，并被山東省企業聯合會評定為山東省質量管理和現場管理樣板單位。
　　十二五期間，辰欣藥業將繼續以科技創新為首要工作，通過引進戰略投資者、上市、合資、增資等多種形式進行融資，增加新產品研發投入，提高新產品技術含量，努力實現2015年銷售收入100億元，利稅20億元的宏偉目標，為中國醫藥事業的發展做出更大的貢獻！

Cisen Pharmaceutical Co., Ltd. is a comprehensive chemical pharmaceutical enterprise. The company has developed into a national hi-tech enterprise, which owns a Post-Doctoral Research workstation, Shandong Taishan scholar posts for Specially Hired specialist on medicines, center of enterprise technology of Shandong and antibiotics engineering technology research center of Shandong, obtains National Development and Reform Committee Industrialization support funds, Shandong Star Enterprise of Chinese Patent etc. The logo of Cisen has been appraised as China famous trademark by SAIC, meanwhile, the company has been selected as the best industrial enterprise of R&D product line of China's Pharmaceutical and enterprise with the best investment value of China's pharmaceutical industry in 2011. Cisen is committed to “Innovation and Integrity”, which is considered as a core value of Cisen. Cisen always adheres to the science and technology as the guide, survive by quality, develop by innovation, forming a path of technological innovation. The company has successively invested and built the first Cisen industrial park, 15 production workshops, and elevated 3-dimensional storehouse. Cisen second industrial park held its grand groundbreaking ceremony on 19 June 2010. The construction of Cisen second industrial park quicken its pace of producing new products with difficult technology, long life cycle, intensive capital and high added value. The company can produce infusion solution(non PVC soft bag infusions, plastic bottle infusions, glass bottle infusions), injection, lyophilized powder injections, tablets, ointments, eye drops, capsules and API etc, 8 series nearly 400 varieties products. Among which, the infusion solution products have been appraised by Shandong province as a famous brand, the single factory capacity of infusion solution ranks No.1 in China and the capacity ranks No.1 in Shandong province. Cisen Pharmaceutical Co., Ltd regards safeguard and promotion for health quality of patients as its own duty and devotes to independently develop and produce drugs to fill the domestic void. Cisen spends 6% of annual sales revenue in its technology research. Cisen has established a strategic relationships with the Pharmaceutical University, Shenyang Pharmaceutical University, Shandong University, Shandong Academy of Medical Sciences, Shandong Institute of pharmaceutical Industry, Institute of Pharmacology under Chinese Sciences, Academy of Military Medical Sciences and other domestic colleges; the company has developed a joint innovation system of “Industry-study-research”. Cisen has established a coordinated process of “Market research-Development and design-Trial production ”and has formed a virtuous cycle of “Develop-Reserve-Production”. New drugs include many category of and more than 100 drugs, such as cardiovascular type, antibacterial, antiviral, anticancer, and so on. Particularly, the anti-HBV Adefovir Dipivoxil Tablets(APIs and tablet) that the company has developed obtains the certificate of State First-Class Innovative Drug, the first prize of technological advancement of Shandong and technological innovation support fund from municipal government, provincial government and Ministry of Science and Technology. The successful development of this drug is a major breakthrough of independent development in the field of HBV drug treatment in China, what has a great significance in promoting technology advancement of China's pharmaceutical industry, quickening the industrialization of China's hi-tech achievements, improving the technology innovation ability of China's pharmaceutical industry and international competitiveness. It will become the engine for promoting the brand value of Cisen as well.